TFA Therapeutics (RAJAF) Cash from Financing Activities (2020 - 2023)
TFA Therapeutics (RAJAF) posted Cash from Financing Activities of $19171.0 for Q4 2023, down 33.75% on a QoQ basis from $28938.0 in Q4 2022, and down 33.75% year-over-year from $28938.0 in Q4 2022.
Powered by 
Analysis
TFA Therapeutics (RAJAF) Cash from Financing Activities (2020 - 2023) Analysis & Trends
TFA Therapeutics has reported Cash from Financing Activities for 3 years, with the latest figure at $19171.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 69.71 Bn | 68.67 Bn | 3.30 Bn | -851.00 Mn |
| 2 | Kenvue | 34.22 Bn | 33.11 Bn | 2.30 Bn | -587.00 Mn |
| 3 | Kimberly Clark | 32.55 Bn | 31.72 Bn | 1.60 Bn | 305.00 Mn |
| 4 | Bath & Body Works | 3.52 Bn | 2.73 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.52 Bn | 2.46 Bn | - | - |
| 6 | Perrigo | 1.88 Bn | 1.49 Bn | 313.90 Mn | -388.90 Mn |
| 7 | Edgewell Personal Care | 1.25 Bn | 854.93 Mn | 242.50 Mn | -7.30 Mn |
| 8 | Herbalife | 1.25 Bn | 883.17 Mn | 1.03 Bn | -82.70 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 611.15 Mn | 505.26 Mn | 40.36 Mn | -15.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 19,171.00 |
| Dec 31, 2022 | 28,938.00 |
| Dec 31, 2020 | 1.63 Mn |